SPHERE多组分新型心理社会干预用于HIV感染者:随机对照试验研究方案
SPHERE是一项在英格兰七家HIV门诊开展的实用型两臂平行组随机对照试验,嵌入常规心理社会需求评估。研究对象为18岁及以上、PO-11评分≥16的HIV感染者,计划纳入568例,按1:1随机分配至健康与福祉教练及社会处方干预组或常规照护组。主要结局为随机化后6个月PO-11评分较基线降低至少40%。
要点
- 针对HIV感染者心理社会需求,评估健康与福祉教练及社会处方干预的效果与成本效果。
- 计划纳入568例PO-11评分≥16的HIV感染者,1:1随机分配至干预组或常规照护组。
- 主要结局为随机化后6个月PO-11评分较基线降低至少40%。
核心结论
- SPHERE试验将评估在HIV二级照护环境中实施心理社会健康与福祉教练的有效性和成本效果。
- 若有效,这种个性化照护模式可能可迁移至其他长期健康状况。
研究设计与样本
- 实用型两臂平行组随机对照试验,在英格兰七家HIV门诊开展,嵌入常规心理社会需求评估。
- 纳入标准为18岁及以上HIV感染者、可在整个研究随访期间参与、心理社会需求评估Positive-Outcomes-11(PO-11)评分≥16分。
- 计划纳入568例参与者,按1:1个体随机分配至健康与福祉教练及社会处方干预组或常规照护组。
- 干预包括最多八次教练会话,由接受过专业培训成为健康与福祉教练的卫生专业人员(如HIV护士)实施。
- 试验还包括内部先导阶段、过程评价(评估干预可行性、可接受性和作用机制)、经济评价(评估成本效果及对NHS资源利用的影响)和平行观察性研究(评估初始不符合试验条件者后续心理社会需求的发展)。
关键数值与推荐
- 主要结局定义为随机化后6个月PO-11评分较基线降低至少40%。
- 次要结局包括抑郁和焦虑症状、社会支持、自我污名、应对自我效能、心理韧性、生活方式因素和健康相关生活质量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antiretroviral therapy (ART) has transformed HIV into a manageable health condition with normal life expectancy. However, people with HIV continue to have poorer mental health compared to background populations, which may be linked to stigma, lack of social support, or socioeconomic challenges. Personalised care aims to improve the outcomes of people with long-term health conditions and the National Health Service (NHS) Long Term Plan looks to implement this (including access to health coaching and social prescribing). The SPHERE trial aims to assess whether a health and well-being coaching and social prescribing intervention improves patient-reported health and well-being among people living with HIV who have psychosocial needs. METHODS: SPHERE will be conducted across seven HIV outpatient clinics in England and is a pragmatic, two-arm, parallel group randomised controlled trial (RCT) embedding a routine assessment of psychosocial needs in HIV care. Eligibility criteria are people living with HIV aged 18 or older, available for the duration of study follow-up and scoring 16 or more on an assessment of psychosocial need: "Positive-Outcomes-11" (PO-11), covering physical, psychological, social and socioeconomic aspects of health and well-being. The RCT requires 568 participants who will be individually randomised in a 1:1 ratio to either a health and well-being coaching and social prescribing intervention or usual care. The intervention consists of up to eight coaching sessions that will be delivered by health professionals (e.g. HIV nurses) who have received specialist training to become health and well-being coaches. The trial will also include an internal pilot phase, process evaluation (to evaluate intervention feasibility, acceptability and mechanisms of action), economic evaluation (to assess the cost-effectiveness of the intervention and impact on NHS resource use) and parallel observational study (to assess subsequent development of psychosocial needs among those not initially eligible for the trial). The primary outcome is defined as achieving a reduction in PO-11 score of at least 40% from baseline to 6 months post-randomisation. Secondary outcomes include symptoms of depression and anxiety, social support, self-stigma, coping self-efficacy, resilience, lifestyle factors and health-related quality of life. DISCUSSION: The SPHERE trial will evaluate the effectiveness and cost-effectiveness of implementing psychosocial health and well-being coaching in a secondary HIV care setting. If effective, this model of personalised care could be transferable to other long-term health conditions. TRIAL REGISTRATION: International Standard Randomised Controlled Trials Number (ISRCTN) Registry: ISRCTN47187932 [registered 12 July 2024].
引用
- Papageorgiou V, Lampe FC, Sewell J, et al. "SPHERE" multi-component novel psychosocial intervention for people with HIV: study protocol for a randomised controlled trial. Trials. 2025. PMID: 40898308. doi:10.1186/s13063-025-08904-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。